Exact Sciences (NASDAQ:EXAS) Price Target Lowered to $65.00 at Bank of America
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price objective decreased by analysts at Bank of America from $72.00 to $65.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the medical research company’s stock. Bank of America‘s price objective suggests a potential upside of […]
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price objective decreased by analysts at Bank of America from $72.00 to $65.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the medical research company’s stock. Bank of America‘s price objective suggests a potential upside of […]
